These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 24440699)

  • 1. Effect of amino acid variations in the central region of human serum amyloid A on the amyloidogenic properties.
    Takase H; Tanaka M; Miyagawa S; Yamada T; Mukai T
    Biochem Biophys Res Commun; 2014 Jan; 444(1):92-7. PubMed ID: 24440699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of regions responsible for heparin-induced amyloidogenesis of human serum amyloid A using its fragment peptides.
    Egashira M; Takase H; Yamamoto I; Tanaka M; Saito H
    Arch Biochem Biophys; 2011 Jul; 511(1-2):101-6. PubMed ID: 21569756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis.
    van der Hilst JC; Yamada T; Op den Camp HJ; van der Meer JW; Drenth JP; Simon A
    Rheumatology (Oxford); 2008 Nov; 47(11):1651-4. PubMed ID: 18815155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human SAA1-derived amyloid deposition in cell culture: a consistent model utilizing human peripheral blood mononuclear cells and serum-free medium.
    Ishii W; Liepnieks JJ; Yamada T; Benson MD; Kluve-Beckerman B
    Amyloid; 2013 Jun; 20(2):61-71. PubMed ID: 23461622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.
    Liu Y; Cui D; Hoshii Y; Kawano H; Une Y; Gondo T; Ishihara T
    Scand J Immunol; 2007 Nov; 66(5):495-500. PubMed ID: 17953525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro amyloid fibril formation by synthetic peptides corresponding to the amino terminus of apoSAA isoforms from amyloid-susceptible and amyloid-resistant mice.
    Kirschner DA; Elliott-Bryant R; Szumowski KE; Gonnerman WA; Kindy MS; Sipe JD; Cathcart ES
    J Struct Biol; 1998 Dec; 124(1):88-98. PubMed ID: 9931277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2.
    Srinivasan S; Patke S; Wang Y; Ye Z; Litt J; Srivastava SK; Lopez MM; Kurouski D; Lednev IK; Kane RS; Colón W
    J Biol Chem; 2013 Jan; 288(4):2744-55. PubMed ID: 23223242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AA amyloidosis-resistant CE/J mice have Saa1 and Saa2 genes that encode an identical SAA isoform.
    Mori M; Tiang G; Higuchi K
    Amyloid; 2014 Mar; 21(1):1-8. PubMed ID: 24228751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A protein AA-variant derived from a novel serum AA protein, SAA1 delta, in an individual from Papua New Guinea.
    Westermark P; Sletten K; Westermark GT; Raynes J; McAdam KP
    Biochem Biophys Res Commun; 1996 Jun; 223(2):320-3. PubMed ID: 8670280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy.
    Elimova E; Kisilevsky R; Szarek WA; Ancsin JB
    FASEB J; 2004 Nov; 18(14):1749-51. PubMed ID: 15345688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryo-EM demonstrates the in vitro proliferation of an ex vivo amyloid fibril morphology by seeding.
    Heerde T; Rennegarbe M; Biedermann A; Savran D; Pfeiffer PB; Hitzenberger M; Baur J; Puscalau-Girtu I; Zacharias M; Schwierz N; Haupt C; Schmidt M; Fändrich M
    Nat Commun; 2022 Jan; 13(1):85. PubMed ID: 35013242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome.
    van der Hilst JC; Drenth JP; Bodar EJ; Bijzet J; van der Meer JW; Simon A;
    Amyloid; 2005 Jun; 12(2):115-9. PubMed ID: 16011988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting misfolding propensity of serum amyloid A1: Special focus on the signal peptide region.
    Haines MS; Ramirez E; Moore KBE; Fortin JS
    Biochem Biophys Rep; 2022 Sep; 31():101284. PubMed ID: 35664543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum amyloid A3 (SAA3), not SAA1 appears to be the major acute phase SAA isoform in the pig.
    Soler L; Luyten T; Stinckens A; Buys N; Cerón JJ; Niewold TA
    Vet Immunol Immunopathol; 2011 May; 141(1-2):109-15. PubMed ID: 21439655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceleration of amyloid fibril formation by carboxyl-terminal truncation of human serum amyloid A.
    Tanaka M; Kawakami T; Okino N; Sasaki K; Nakanishi K; Takase H; Yamada T; Mukai T
    Arch Biochem Biophys; 2018 Feb; 639():9-15. PubMed ID: 29288051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis.
    Patel H; Bramall J; Waters H; De Beer MC; Woo P
    Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):1041-9. PubMed ID: 8836154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1.
    Liepnieks JJ; Kluve-Beckerman B; Benson MD
    Biochim Biophys Acta; 1995 Jan; 1270(1):81-6. PubMed ID: 7827140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syrian and Armenian hamsters differ in serum amyloid A gene expression. Identification of novel Syrian hamster serum amyloid A subtypes.
    de Beer MC; de Beer FC; Beach CM; Gonnerman WA; Carreras I; Sipe JD
    J Immunol; 1993 Jun; 150(12):5361-70. PubMed ID: 8515064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key charged residues influence the amyloidogenic propensity of the helix-1 region of serum amyloid A.
    Bilog M; Vedad J; Capadona C; Profit AA; Desamero RZB
    Biochim Biophys Acta Gen Subj; 2024 Nov; 1868(11):130690. PubMed ID: 39117048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis.
    Lu J; Yu Y; Zhu I; Cheng Y; Sun PD
    Proc Natl Acad Sci U S A; 2014 Apr; 111(14):5189-94. PubMed ID: 24706838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.